Merck (MRK) Enterprise Value (2009 - 2026)
Merck's Enterprise Value was $358.7 billion in Q3 2026, up 88.6% from $190.16 billion a year earlier and up 15.7% from the prior quarter.
Powered by 
Analysis
Merck (MRK) Enterprise Value (2009 - 2026) Analysis & Trends
For FY2025, Enterprise Value at Merck came in at $245.73 billion, up 3.4% from FY2024.
- Enterprise Value shows a five-year compound annual growth rate of 5.3% (FY2020 to FY2025).
- In earlier years, Enterprise Value was $237.66 billion in FY2024 (-11.7%), $269.07 billion in FY2023 (+0.2%), $268.53 billion in FY2022 (+44.6%) and $185.7 billion in FY2021 (-2.0%).
- The Q3 2026 figure marks the highest quarterly Enterprise Value in data going back to Q1 2009.
- Compared with a year earlier, Enterprise Value has increased for four straight quarters, with growth averaging 9.6% over the last eight quarters.
- The best year-over-year quarter for Enterprise Value over five years was Q3 2026 (growth of 88.6%); the worst was Q2 2025 (a decline of 37.5%).
- Per Business Quant data, MRK's Enterprise Value in the three quarters before Q3 2026 was $309.94 billion (Q2 2026), $291.45 billion (Q1 2026) and $245.73 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 348.83 Bn |
| Jun 30, 2026 | 309.94 Bn |
| Mar 31, 2026 | 291.45 Bn |
| Dec 31, 2025 | 245.73 Bn |
| Sep 30, 2025 | 190.16 Bn |
| Jun 30, 2025 | 189.17 Bn |
| Mar 31, 2025 | 216.23 Bn |
| Dec 31, 2024 | 237.66 Bn |
| Sep 30, 2024 | 272.73 Bn |
| Jun 30, 2024 | 302.52 Bn |
| Mar 31, 2024 | 328.64 Bn |
| Dec 31, 2023 | 269.07 Bn |
| Sep 30, 2023 | 252.16 Bn |
| Jun 30, 2023 | 286.48 Bn |
| Mar 31, 2023 | 259.64 Bn |
| Dec 31, 2022 | 268.53 Bn |
| Sep 30, 2022 | 207.17 Bn |
| Jun 30, 2022 | 220.91 Bn |
| Mar 31, 2022 | 198.63 Bn |
| Dec 31, 2021 | 185.70 Bn |
API Access
Merck Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();